APA (7th ed.) Citation

Sanada, F., Kanbara, Y., Taniyama, Y., Otsu, R., Carracedo, M., Ikeda-Iwabu, Y., . . . Morishita, R. (2016). Induction of Angiogenesis by a Type III Phosphodiesterase Inhibitor, Cilostazol, Through Activation of Peroxisome Proliferator-Activated Receptor-γ and cAMP Pathways in Vascular Cells. Arteriosclerosis, thrombosis, and vascular biology, 36(3), 545-552. https://doi.org/10.1161/ATVBAHA.115.307011

Chicago Style (17th ed.) Citation

Sanada, Fumihiro, et al. "Induction of Angiogenesis by a Type III Phosphodiesterase Inhibitor, Cilostazol, Through Activation of Peroxisome Proliferator-Activated Receptor-γ and CAMP Pathways in Vascular Cells." Arteriosclerosis, Thrombosis, and Vascular Biology 36, no. 3 (2016): 545-552. https://doi.org/10.1161/ATVBAHA.115.307011.

MLA (9th ed.) Citation

Sanada, Fumihiro, et al. "Induction of Angiogenesis by a Type III Phosphodiesterase Inhibitor, Cilostazol, Through Activation of Peroxisome Proliferator-Activated Receptor-γ and CAMP Pathways in Vascular Cells." Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 36, no. 3, 2016, pp. 545-552, https://doi.org/10.1161/ATVBAHA.115.307011.